drugset / Trial / NCT02549989
Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effectiveness of LY3023414 in treating the participants type of cancer and to determine the types and severity of side effects caused by treatment with LY3023414.
Timeline
- Start
- 2015-09
- Primary completion
- 2022-03-23
- Completion
- 2022-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Samotolisib | Small molecule | 200 mg | Oral |